First population-level results of pre-biopsy prostate MRI
DOI:
https://doi.org/10.2340/sju.v58.18509Keywords:
Prostate cancer, Diagnostics, Magnetic resonance imaging, Targeted biopsy, Overdiagnosis, PopulationDownloads
References
Xie J, Liu M, Sun K, et al. MRI/transrectal ultrasound fusion-guided targeted biopsy and transrectal ultrasound-guided systematic biopsy for diagnosis of prostate cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:880336. https://doi.org/10.3389/fonc.2022.880336 DOI: https://doi.org/10.3389/fonc.2022.880336
Bratt O, Carlsson S, Fransson P, et al. The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease. Scand J Urol. 2022;56:265–273. https://doi.org/10.1080/21681805.2022.2094462 DOI: https://doi.org/10.1080/21681805.2022.2094462
Robinson D, Abdulkareem R, Nasrollah D, et al. Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging. JAMA Netw Open. 2023;6:e2330233. https://doi.org/10.1001/jamanetworkopen.2023.30233 DOI: https://doi.org/10.1001/jamanetworkopen.2023.30233
Bratt O. The long and winding road from guideline recommendations to improved quality of care. Eur Urol 2023;83:402–404. https://doi.org/10.1016/j.eururo.2023.01.011 DOI: https://doi.org/10.1016/j.eururo.2023.01.011
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ola Bratt
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
